14 days before the date of the surgery every participant will have implemented the device for continuous glycemia measurement (Dexcom)

Right after the surgery every participant will have implemented the device for continuous glycemia measurement (Dexcom). During standard control visit 14 days after the surgery for skin sutures removal the device will be taken out and data of whole period of time will be collected

Osteoarthritis, Knee

Osteoarthritis, Hip

Hyperglycemia

Diabetes Mellitus, Type 2

14 days before the date of the surgery and after the surgery patient will have implemented the device for continuous glycemia measurement (Dexcom). During standard control visit 14 days after the surgery for skin sutures removal the device will be taken out and data of whole period of time will be collected

Continuous glycemia measuring device (Dexcom) implantation into the subcutaneous tissue

Continuous Glycemia Monitoring in Perioperative Period in Patients Undergoing Total Knee or Hip Arthroplasty

Influence of Continuous Glycemia Monitoring in Perioperative Period on Complications Including Cardiovascular and Clinical Outcome in Patients Undergoing Total Knee or Hip Arthroplasty - Prospective Interventional Study

Continuous glycemia level monitoring with use of subcutaneously implanted device

Any cardiovascular events during follow-up (heart stroke, brain stroke, coronal arteries disease, transient ischaemic attack (TIA)

Any surgical site and/or implants complications during follow-up

KOOS is a questionnaire designed to assess patient-relevant outcomes following knee injury. The KOOS assesses outcomes: pain, symptoms, activities of daily living, sport and recreation function, and knee-related quality of life. All items have five possible answer options scored from 0 (No problems) to 4 (Extreme problems). Scores between 0 and 100 represent the percentage of total possible score achieved.

Correlation of FINDRISC scale results with cardiovascular events and/or surgical site or implants complications

Artur Stolarczyk

Head of the Department of Orthopedics and Rehabilitation

Medical University of Warsaw

The drop in cardiac output after spinal anaesthesia for LSCS at various intervals with LiDCORapid

Low Cardiac Output

Cardiac output will be non invasively monitored by using 2 cuffs on fingers.

LiDCOrapid

Aberdeen Maternity Hospital

Comparative Study of Haemodynamic Changes After Spinal Anaesthesia in Non-obese and Pregnant Women

The change in cardiac output from baseline measured as milliliters/minute at predetermined intervals after spinal anaesthesia will be recorded in each group. The mean value of this change in each group will be compared for each recording and the difference in the change between the two groups will be reported.

University of Aberdeen

Participation involves the collection of one blood sample (3.0 ml) in an EDTA (lavender top) tube for pharmacogenetic testing. Genomic DNA will be extracted using standard procedures. Participation in pharmacogenetic testing is optional and requires additional consent; subjects who refuse pharmacogenetifc testing may still be enrolled in this study.

unconsciousness/سمنة

Continuous Glycemia Monitoring in Perioperative Period in Patients Undergoing Total Knee or Hip Arthroplasty

Comparative Study of Haemodynamic Changes After Spinal Anaesthesia in Non-obese and Pregnant Women

Development of PK/PD Model for Individualized Propofol Dosing

قاعدة بيانات الأعشاب الطبية الأكثر اكتمالا التي يدعمها العلم